Google Ventures is betting more and more on life sciences startups each year, and the well-funded financier tells The Wall Street Journal that's not going to change in the new year.
Autism Speaks has released details of the genome sequencing database it is building on Google's cloud platform. The plan is to sequence the whole genomes of 10,000 people in families affected by autism and make the resulting database freely available to researchers.
23andMe has found regulators in the United Kingdom more amenable to its personal genomics service than the U.S. FDA. The U.K. Medicines and Healthcare Products Regulatory Agency has given cautious backing to the company's spit test, which has a CE mark clearing it for sale in Europe.
A choice bioinformatics position just opened up at Calico. The secretive, Google-backed anti-aging biotech is recruiting a head of bioinformatics to lead the creation of infrastructure and tools for acquiring and processing sequence data.
The head of Google's life sciences team drummed up already-high interest in the company's developmental stage wearable diagnostic. The device will use magnets to "call" diagnostic nanoparticles so small that millions fit within a grain of sand, said life science team leader and Google X lab member Andrew Conrad at the WSJD Live conference
Google is going after your genome. The search giant has spent the past 18 months building its Google Genomics platform and pitching it to researchers as a way to store human genomes for $25 each per year.
The space occupied by Google Flu Trends is becoming more congested. One year after the Centers for Disease Control and Prevention put out a call for ways to use digital data to forecast the flu season, details of the entrants' models are still trickling in as academic papers are published.
Diagnostics luminary Foundation Medicine is generating some upward momentum, fueled by growing revenues and the success of its clinical tests. Tech giant Google has taken note and is signing onto the company's cancer diagnostics by offering them to employees.
Google has made the biggest change to its Flu Trends influenza tracking software since it first released the system in 2008. The update incorporates data from the Centers for Disease Control and Prevention in an attempt to improve the accuracy of the model.
Google has dedicated more than 100 employees from multiple disciplines to making its vision of nanotechnology-enabled detection of cancer and other diseases a reality. Any tangible product resulting from this ambitious effort is at least 5 to 7 years away.